Abstract
Background
Dynamic magnetic resonance imaging (MRI) has improved the detection of breast malignancies. The method is based on estimating the velocity of contrast enhancement taking into account increased angiogenesis in tumor. Microvessel density correlates with breast carcinoma metastasis. Thus, we hypothesized that contrast enhancement on MRI correlates with metastasis in breast cancer patients. The present study attempts to clarify the quantitative assessment of dynamic data, and examines the correlation between MRI enhancement and breast carcinoma metastasis.
Methods
The subjects consisted of 31 patients with invasive ductal breast cancer. Twenty patients were disease free for five years (group A), and eleven patients suffered from metastatic disease at distant sites concurrently or postoperatively (group B). Dynamic MRI was performed preoperatively using a 1.5T system in all cases. Using the dynamic data, the signal intensity (SI) ratio and SI index were determined and analyzed retrospectively taking into account the presence of distant metastases.
Results
The values of the SI ratio were 2.2 ± 0.7 in group A and 2.3 ± 0.4 in group B, respectively, with no significant difference seen between the groups. The SI index value was significantly higher in group B (28.5 ± 32.8) than in group A (10.3 ± 5.5,p < 0.05).
Conclusions
The current series suggests that the SI index could distinguish patients with high risk of distant metastasis from disease free patients, preoperatively. If a suitable borderline value were established, the quantitative dynamic parameter determined by MRI may be useful for predicting the prognosis of breast cancer patients.
Similar content being viewed by others
Abbreviations
- SI:
-
Signal intensity
- MRI:
-
Magnetic resonance imaging
- SE:
-
Spin echo
- FOV:
-
Field of view
- SPGR:
-
Spoiled gradient echo
- Gd-DTPA:
-
Gadolinium-diethylene triamine pentaacetic acid
- ROI:
-
Region of interest
References
Mussurakis S, Buckley DL, Coady AM, Turnbull LW, and Horsman A: Observer variability in the interpretation of contrast enhanced MRI of the breast.Br J Radiol 69: 1009–1016, 1996.
Harms SE, Flamig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, Savino DA, and Wells RV: MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation.Radiology 187: 493–501, 1993.
Orel SG, Schnall MD, Powell CM, Hochman MG, Solin LJ, Fowble BL, Torosian MH, and Rosato EF: Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy.Radiology 196: 115–122, 1995.
Piccoli CW: Contrast-enhanced breast MRI: factors affecting sensitivity and specificity.Eur Radiol 7 (Suppl5): 281–288, 1997.
Buadu LD, Murakami J, Murayama S, Hashiguchi N, Sakai S, Masuda K, Toyoshima S, Kuroki S, and Ohno S: Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis.Radiology 200: 639–649, 1996.
Liney GP, Gibbs P, Hayes C, Leach MO, and Turnbull LW: Dynamic contrast-enhanced MRI in the differentiation of breast tumors: user-defined versus semiautomated region-of-interest analysis.J Magn Reson Imaging 10: 945–949, 1999.
Stamper PC, Herman S, Klippenstein DL, Winston JS, Edge SB, Arredondo MA, Mazurchuk RV, and Blumenson LE: Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features.Radiology 197: 387–395, 1995.
Schorn C, Fischer U, Luftner-Nagel S, and Grabbe E: Diagnostic potential of ultrafast contrast-enhanced MRI of the breast in hypervascularized lesions: are there advantages in comparison with standard dynamic MRI?J Comput Assist Tomogr 23: 118–122, 1999.
Heywang-Kobrunner SH: Contrast-enhanced magnetic resonance imaging of the breast.Invest Radiol 29: 94–104, 1994.
Furman-Haran E, Margalit R, Grobgeld D, and Degani H: Dynamic contrast-enhanced magnetic resonance imaging reveals stress-induced angiogenesis in MCF7 human breast tumors.Proc Natl Acad Sci USA 93: 6247–6251, 1996.
Degani H, Furman E, and Fields S: Magnetic resonance imaging and spectroscopy of MCF7 human breast cancer: pathophysiology and monitoring of treatment.Clin Chim Acta 228: 19–33, 1994.
Stack JP, Redmond OM, Codd MB, Dervan PA, and Ennis JT: Breast disease: tissue characterization with Gd-DTPA enhancement profiles.Radiology 174: 491–494, 1990.
Boetes C, Barentsz JO, Mus RD, van der Sluis RF, van Erning LJ, Hendriks JH, Holland R, and Ruys SH: MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique.Radiology 193: 777–781, 1994.
Kerslake RW, Carleton PJ, Fox JN, Imrie MJ, Cook AM, Read JR, Bowsley SJ, Buckley DH, and Horsman A: Dynamic gradient-echo and fat-suppressed spinecho contrast-enhanced MRI of the breast.Clin Radiol 50: 440–454, 1995.
Weinreb JC, and Newstead G: MR imaging of the breast.Radiology 196: 593–610, 1995.
Weidner N, Semple JP, Welch WR, and Folkman J: Tumor angiogenesis and metastasis — correlation in invasive breast carcinoma.N Engl J Med 324: 1–8, 1991.
Horak ER, Leek R, Klenk N, Lejeune S, Smith K, Stuart N, Greenall M, Stepniewska K, and Harris AL: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer.Lancet 340: 1120–1124, 1992.
Liotta LA, Kleinerman J, and Saidel GM: Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation.Cancer Res 34: 997–1004, 1974.
Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ, and Silverman ML: Microvessel quantitation and prognosis in invasive breast carcinoma.Hum Pathol 23: 755–761, 1992.
Toi M, Kashitani J, and Tominaga T: Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma.Int J Cancer 55: 371–374, 1993.
Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, and Gasparini G: Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.J Natl Cancer Inst 84: 1875–1887, 1992.
Gasparini G, and Harris AL: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool.J Clin Oncol 13: 765–782, 1995.
Kyistad KA, Rydland J, Smethurst HB, Lundgren S, Fjosne HE, and Haraldseth O: Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI.Eur Radiol 10: 1464–1471, 2000.
Kuhl CK, Bieling H, Gieseke J, Ebel T, Mielcarek P, Far F, Folkers P, Elevelt A, and Schild HH: Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.Radiology 202: 87–95, 1997.
Buckley DL, Drew PJ, Mussurakis S, Monson JR, and Horsman A: Microvessel density of invasive breast cancer assessed by dynamic Gd-DTPA enhanced MRI.J Magn Reson Imaging 7: 461–464, 1997.
van Dijke CF, Brasch RC, Roberts TP, Weidner N, Mathur A, Shames DM, Mann JS, Demsar F, Lang P, and Schwickert HC: Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density.Radiology 198: 813–818, 1996.
Folkman J, and Shing Y: Angiogenesis.J Biol Chem 267: 10931–10934, 1992.
Heywang SH, Hahn D, Schmidt H, Krischke I, Eiermann W, Bassermann R, and Lissner J: MR imaging of the breast using gadolinium-DTPA.J Comput Assist Tomogr 10: 199–204, 1986.
Ercolani P, Valeri G, and Amici F: Dynamic MRI of the breast.Eur J Radiol 27 Suppl 2: S 265–271, 1998.
Folkman J, and Klagsbrun M: Angiogenic factors.Science 235: 442–447, 1987.
Folkman J, Watson K, Ingber D, and Hanahan D: Induction of angiogenesis during the transition from hyperplasia to neoplasia.Nature 339: 58–61, 1989.
Pham CD, Roberts TP, van Bruggen N, Melnyk O, Mann J, Ferrara N, Cohen RL, and Brasch RC: Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor.Cancer Invest 16: 225–230, 1998.
Kuhl CK, and Schild HH: Dynamic image interpretation of MRI of the breast.J Magn Reson Imaging 12: 965–974, 2000.
Fidler IJ: Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture.Cancer Res 50: 6130–6138, 1990.
Ellis LM, and Fidler IJ: Angiogenesis and breast cancer metastasis.Lancet 346: 388–390, 1995.
Folkman J: What is the evidence that tumors are angiogenesis dependent?J Natl Cancer Inst 82: 4–6, 1990.
Blood CH, and Zetter BR: Tumor interactions with the vasculature: angiogenesis and tumor metastasis.Biochim Biophys Acta 1032: 89–118, 1990.
Liotta LA, and Stracke ML: Tumor invasion and metastases: biochemical mechanisms.Cancer Treat Res 40: 223–238, 1988.
Ogawa Y, Chung YS, Nakata B, Takatsuka S, Maeda K, Sawada T, Kato Y, Yoshikawa K, Sakurai M, and Sowa M: Microvessel quantitation in invasive breast cancer by staining for factor Hi-related antigen.Br J Cancer 71: 1297–1301, 1995.
Van Hoef ME, Knox WF, Dhesi SS, Howell A, and Schor AM: Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer.Eur J Cancer 29: 1141–1145, 1993.
Author information
Authors and Affiliations
Additional information
Reprint requests to Takeshi Nagashima, Department of General Surgery, Chiba University Graduate School of Medicine, 1-8-1 Inohana, Chuo-ku, Chiba 260-0856, Japan.
About this article
Cite this article
Nagashima, T., Suzuki, M., Yagata, H. et al. Dynamic-enhanced MRI predicts metastatic potential of invasive ductal breast cancer. Breast Cancer 9, 226–230 (2002). https://doi.org/10.1007/BF02967594
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02967594